Previous Statements by IDXX
» IDEXX Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript
» IDEXX Laboratories Inc. Q4 2008 Earnings Call Transcript
» IDEXX Laboratories, Inc. Q2 2008 Earnings Call Transcript
Biogen's new spine disease drug outperformed expectations during its commercial debut.
Jim Cramer looks at how the French elections are smacking the U.S stock markets. Plus, he has the week-ahead game plan for oil and stocks.